Praxis Precision Medicines (PRAX) Gets a Buy From Piper Sandler

TipRanksJul 18 06:39 ET

Nvidia, Micron Leading Chip Stocks Higher Tuesday

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.Shares of NVIDIA Corporation (NASDAQ:NVDA) rose during Tuesday's session.Keybanc analyst John Vinh maintained

BenzingaJul 9 10:05 ET

Praxis Precision Med Is Maintained at Overweight by Piper Sandler

Praxis Precision Med Is Maintained at Overweight by Piper Sandler

Dow JonesJul 1 10:00 ET

Piper Sandler Initiates a Buy Rating on Praxis Precision Medicines (PRAX)

TipRanksJul 1 06:36 ET

Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst

Needham initiated coverage on Praxis Precision Medicines Inc (NASDAQ:PRAX), a clinical-stage biopharmaceutical company, engaged in the development of therapies for central nervous system disorders.The

BenzingaJun 24 15:54 ET

Needham Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $145

Needham analyst Ami Fadia initiates coverage on $Praxis Precision Medicines(PRAX.US)$ with a buy rating, and sets the target price at $145.According to TipRanks data, the analyst has a success rate of

Moomoo NewsJun 24 06:31 ET · Ratings